Prenatal Opioid Exposure and Subsequent Risk of Fractures in Children: An Emulated Target Trial Using a Nationwide

Hyohyeon Lee1, Kyeongeun Kim2,3, Yeona Jo2,3

  • 1School of Health and Environmental Science, College of Health Science, Korea University, Seoul, South Korea.

Indian Pediatrics
|June 19, 2026
PubMed

Insights

Prenatal opioid exposure did not significantly increase childhood fracture risk overall. However, high-dose or prolonged exposure may warrant caution regarding bone health.

Area of Science:

  • Pediatric Health
  • Pharmacology
  • Epidemiology

Background:

  • Prenatal opioid exposure is a growing concern for child development.
  • Its impact on childhood musculoskeletal health, specifically fracture risk, remains understudied.

Purpose of the Study:

  • To investigate the association between prenatal opioid exposure and the risk of fractures in children.
  • To analyze site-specific fracture risks and dose-response relationships.

Main Methods:

  • Utilized Korean National Health Insurance Service claims data (2009-2023) to emulate a target trial.
  • Defined prenatal opioid exposure as ≥2 maternal opioid prescriptions per trimester.
  • Employed propensity score matching and sibling comparison designs with Cox proportional hazards models.

Main Results:

  • Identified over 700,000 children, with ~117,000 exposed prenatally to opioids.
  • Prenatal opioid exposure showed a slight increase in fracture risk (aHR 1.07), but this was not significant in sibling analyses.
  • Fracture risk increased in a dose-dependent manner with higher opioid exposure levels.

Conclusions:

  • Overall prenatal opioid exposure was not linked to a substantial increase in childhood fracture risk.
  • High-dose, prolonged, or frequent prenatal opioid exposure may necessitate continued monitoring and caution.
  • Further research is needed to fully elucidate the long-term musculoskeletal effects.
Abstract